YEM-23506-89379
2 vaccinations
6 coded responses
22 check-ins
6 free-text entries
0 call cases
- Sex
- Male
- Age at first dose
- 61-65
- ZIP prefix
- 900 / CA
- Registered
- 2021-02-27
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-02-27
Registered in v-safe
-
2021-02-27
Dose 1 — Moderna
-
2021-02-27
Survey response — day 0, dose 1MedDRA: Arthralgia — Feeling: Good · Site: Pain · Joint painsFree text: Finger joints on left hand slightly sore. Injection was to left arm. Right hand is unaffected.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-01
Survey response — days 1–6 daily, dose 1MedDRA: Injection site pain, Mobility decreased, Pain, Pain in extremity — Feeling: Good · Site: Pain · Joint pains, Muscle or body achesFree text: Sunday was much worse. Pain limited use of my left arm, and I had general aching. Today it is just the arm and my use of it is not limited.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-03-02
- 2021-03-03
- 2021-03-04
- 2021-03-05
- 2021-03-06
- 2021-03-17
- 2021-03-20
-
2021-03-27
Dose 2 — Moderna
-
2021-03-29
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain · Muscle or body aches, Fatigue or tirednessAdult check-in
-
2021-03-30
Survey response — days 1–6 daily, dose 2MedDRA: Condition aggravated, Pre-existing disease — Feeling: Good · Fatigue or tirednessFree text: This is probably unrelated but my cornea was scratched due to an accumulation of dried eye productions that functioned like sand to damage the eye. This happened once before, before I had received any inoculation for COVID.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-31
Survey response — days 1–6 daily, dose 2MedDRA: Flushing, Rash — Feeling: Good · Fatigue or tiredness, Rash, not including the immediate area around the injection siteFree text: The rash was very light red on my arms and legs. It was hard to distinguish from mere flushing, but it was not normal. It went away in a few hours. Hardly any itching.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-01
Survey response — days 1–6 daily, dose 2MedDRA: Rash — Feeling: Good · Rash, not including the immediate area around the injection siteFree text: The rash once again comes and goes and is just a slight redness in mostly forearms and lower legs. Skin feels subtly different but there is no pain or itching.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-04-03
- 2021-04-10
- 2021-04-17
- 2021-04-24
- 2021-05-01
- 2021-05-09
- 2021-06-26
- 2021-09-25
-
2022-03-27
Survey response — 12 months, dose 2MedDRA: Chalazion, Eyelid disorder, Meibomian gland dysfunction — Feeling: GoodFree text: Meibomian gland dysfunction affecting eyelids and related chelazion.MedDRA releases: 2024-11 · check-in free text available
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-02-27 | Moderna | |
| 2 | 2021-03-27 | Moderna |
Free text
Release 4 — day 0, dose 1
Systemic reaction (other): Finger joints on left hand slightly sore. Injection was to left arm. Right hand is unaffected.
Release 4 — days 1–6 daily, dose 1
Systemic reaction (other): Sunday was much worse. Pain limited use of my left arm, and I had general aching. Today it is just the arm and my use of it is not limited.
Release 6 — days 1–6 daily, dose 2
Systemic reaction (other): This is probably unrelated but my cornea was scratched due to an accumulation of dried eye productions that functioned like sand to damage the eye. This happened once before, before I had received any inoculation for COVID.
Systemic reaction (other): The rash was very light red on my arms and legs. It was hard to distinguish from mere flushing, but it was not normal. It went away in a few hours. Hardly any itching.
Systemic reaction (other): The rash once again comes and goes and is just a slight redness in mostly forearms and lower legs. Skin feels subtly different but there is no pain or itching.
Release 11 — 12 months, dose 2
Symptoms: Meibomian gland dysfunction affecting eyelids and related chelazion.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Chalazion | · | · | ✓ |
| SD | Eyelid disorder | · | · | ✓ |
| SD | Meibomian gland dysfunction | · | · | ✓ |
| SRO | Arthralgia | ✓ | ✓ | ✓ |
| SRO | Condition aggravated | ✓ | ✓ | ✓ |
| SRO | Flushing | ✓ | ✓ | ✓ |
| SRO | Injection site pain | ○ | ✓ | ○ |
| SRO | Mobility decreased | ✓ | · | ✓ |
| SRO | Pain | ✓ | ✓ | ✓ |
| SRO | Pain in extremity | ✓ | · | ✓ |
| SRO | Pre-existing disease | ✓ | ✓ | ✓ |
| SRO | Rash | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release